LONDON, Dec. 6, 2022 /PRNewswire/ -- Clarivate Plc
(NYSE: CLVT), a global leader in providing trusted information and
insights to accelerate the pace of innovation, today announced the
inclusion of linked specialty pharmacy claims data within real
world data solutions. The new U.S. dataset will expand the real
world data and analytics offerings from Clarivate. Researchers can
access an in-depth view of high-cost medications and valuable
insights into the patient's treatment journey in chronic, complex
and rare diseases, such as rheumatoid arthritis (e.g., Humira,
Enbrel), inflammatory conditions (e.g., Dupixent, Otezla), and
cancer (e.g., Xgeva, Xeloda).
Specialty drugs cover at least 20% of the market for chronic,
complex and rare diseases. However, conventional claims data
warehouses rarely include these high-cost medications, which limits
the research potential of numerous diseases. Specialty pharmacy
data enables life sciences professionals to:
- Track specialty drug uptake and understand market dynamics
(market and launch analytics)
- Build brand-level patient profiles (brand analytics, patient
journey)
- Measure non/adherence and switching patterns (persistency and
adherence analysis)
- Target and appropriately engage prescribers and providers
(commercial targeting)
Researchers can leverage this real-world dataset to make
evidence-based decisions -- developing successful strategies,
optimizing commercial resources, and defining the right activities
and messaging to improve patient outcomes.
Matt McKinley, VP, Head of
Real World Data & Analytics, said: "Clarivate is committed
to supporting customers across the drug, device and diagnostic
lifecycle with timely, fit-for-purpose real world data solutions.
The addition of integrated, high-capture specialty pharmacy data to
the Clarivate portfolio further expands the set of questions that
can be answered in the data by reducing fragmentation and bias and
providing a more holistic view of the patient."
The specialty pharmacy data covers over 500 specialty drugs
spanning diverse therapeutic areas. The data enables a holistic
analysis of complex clinical profiles reducing the need for
additional data mapping or processing. The unique data and insights
are updated weekly, allowing users to track changes in clinical
pathways, product uptake and market dynamics.
To learn more about real world data insights provided by
Clarivate, visit here.
About Clarivate
Clarivate™ is a global leader in providing solutions
to accelerate the pace of innovation. Our bold mission is to help
customers solve some of the world's most complex problems by
providing actionable information and insights that reduce the time
from new ideas to life-changing inventions in the areas of Academia
& Government, Life Sciences & Healthcare, Professional
Services and Consumer Goods, Manufacturing & technology. We
help customers discover, protect and commercialize their inventions
using our trusted subscription and technology-based solutions
coupled with deep domain expertise. For more information, please
visit clarivate.com.
Media contact:
Catherine Daniel
Director External Communications, Life Sciences &
Healthcare
newsroom@clarivate.com
Logo -
https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/clarivate-expands-real-world-data-and-analytics-solutions-with-addition-of-us-specialty-pharmacy-data-301695557.html